Browsing by Subject France

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 20 of 90  next >
The advertising of alcohol in France / Vincent-Pierre Comiti
Comiti, Vincent-Pierre ( 1990 )
AIDS talks for adolescents / Catherine Manuel ... [et al.]
Manuel, Catherine; Molines, Catherine; Dubuc, Myriam; San Marco, Jean Louis ( 1998 )
And toxic flows the Rhine! / by Valery Abramov
Abramov, Valery ( 1987 )
Aspects organisationnels du système de financement de la santé français : réforme de l'Assurance Maladie Obligatoire
Organisation mondiale de la Santé ( 2009 )
Ayant examiné le rapport du Directeur régional sur ce sujet-Document AFR/RC12/5 and Add.1.
Comité régional de l'Afrique, 12 ( 1962 )
A better prospect for city life / Anne Sabouraud
Sabouraud, Annette ( 1992 )
Bismuth salts in diarrhoea : modest benefit at substantial cost : reports on individual drugs
( 1996 )
Charlas sobre el SIDA para adolescentes / Catherine Manuel ... [et al.]
Manuel, Catherine; Molines, Catherine; Dubuc, Myriam; San Marco, Jean Louis ( 1998 )
Climate and health country profile 2015: France
World Health Organization ( 2016 )
La contaminación atmosférica sigue constituyendo un problema de salud pública en París / Sylvia Medina ... [et al.]
Medina, Sylvia; Dab, William; Quénel, Philippe; Ferry, Ruth; Festy, Bernard ( 1996 )
The content and structure of methadone treatment programmes : a study in six countries / by Michael Gossop and Marcus Grant
Gossop, Michael; Grant, Marcus; World Health Organization. Programme on Substance Abuse ( 1990 )
Cross-national comparability of burden of disease estimates : the European Disability Weights Project / Marie-Louise Essink-Bot ... [et al.]
Essink-Bot, Marie-Louise; Pereira, Joaquin; Packer, Claire; Schwarzinger, Michael; Burström, Kristina; European Disability Weights Group ( 2002 )
La cure de santé des plages bretonnes / Louis Roger Dautriat
Dautriat, Louis Roger ( 1992 )
The Current status of antimicrobial resistance surveillance in Europe : report of a WHO workshop held in collaboration with the Italian Associazione Culturale Microbiologia Medica, Verona, Italy, 12 December 1997
World Health Organization. Division of Emerging and Communicable Diseases Surveillance and Control ( 1998 )
Disparités géographiques en économie de la santé : l' exemple de la France / S. Andréani, A. Mizrahi et F. Tonnellier
Andréani, S; Mizrahi, Arié; Tonnellier, François ( 1987 )
Epidemiological fact sheets on HIV/AIDS and sexually transmitted diseases : European region
UNAIDS/WHO Working Group on Global HIV/AIDS and STD Surveillance ( 1998 )
Epidemiología de la fascioliasis humana : revisión y propuesta de nueva clasificación / M. S. Mas-Coma, J. G. Esteban y M. D. Bargues
Mas-Coma, M. S; Esteban, J. G; Bargues, M. D ( 1999 )
Epidemiology of human fascioliasis : a review and proposed new classification / M. S. Mas-Coma, J. G. Esteban and M. D. Bargues
Mas-Coma, M. S; Esteban, J. G; Bargues, M. D ( 1999 )
Epidémiologie de la distomatose hépatique humaine : bilan et projet de nouvelle classification / M. S. Mas-Coma, J. G. Esteban et M. D. Bargues
Mas-Coma, M. S; Esteban, J. G; Bargues, M. D ( 1999 )
European Advisory Group on the Expanded Programme on Immunization : report on the 12th meeting, Copenhagen, Denmark, 21 November 1996
European Advisory Group on the Expanded Programme on Immunization. Meeting (12th: 1996: Copenhagen, Denmark); World Health Organization. Regional Office for Europe ( 1997 )

At its twelfth meeting, the European Advisory Group (EAG) confirmed that the first priority for measles control was the achievement of high coverage with a single dose of vaccine, though this would not serve to eliminate the disease. The interruption of transmission needed to be maintained, and this could be achieved with supplementary vaccination, either through repeated campaigns or by the administration of second doses. Whichever approach was used, it was essential that the reaccumulation of susceptibles was prevented. The EAG endorsed the importance of achieving very high coverage of primary immunization with DTP vaccine. This should be completed before six months of age. The first booster could be given at 16-36 months of age, with another (DT) before school entry and a third (Td) on leaving school. This recommendation applied to all European countries. In a number of countries, especially those presently experiencing or having recently experienced epidemic diphtheria, a further booster should be given during the school years. Where the risk of diphtheria was considered high, periodic booster doses for adults would be necessary to prevent resurgence of the disease as immunity waned. On poliomyelitis, the EAG noted the significant impact of Operation MECACAR and the increasing awareness that remaining outbreaks of poliomyelitis in the Region had often followed importation of the disease. The EAG endorsed the plan of action for 1997 proposed by the Regional Office. In countries where poliomyelitis was still endemic or had become nonendemic within the past three years, the surveillance of acute flaccid paralysis (AFP) remained the recommended form of surveillance, especially for certification purposes. However, in countries where polioviruses had not been detected for many years, and AFP surveillance was not appropriate, other means of surveillance would need to be used. The EAG recommended that the Regional Office commission a position paper to review the options for laboratory-based or other surveillance techniques, so that appropriate guidelines could be issued

Showing results 1 to 20 of 90  next >